SCHEMBL19208032

SCHEMBL19208032

COc1[c]c(O)cc(Br)c1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39
HSD17B10 Q99714 1/20 0.36
ERN1 O75460 1/20 0.35
TDP1 Q9NUW8 2/20 0.33
APP P05067 1/20 0.33
ALOX5 P09917 1/20 0.32
PTGS2 P35354 1/20 0.32
CYP3A4 P08684 2/20 0.32
MAPT P10636 1/20 0.32
TSHR P16473 1/20 0.32
TPMT P51580 1/20 0.32
GABRA1 P14867 1/20 0.31
GABRB1 P18505 1/20 0.31
CA2 P00918 1/20 0.31
CA4 P22748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20562919 0.84 HSD17B10 (0.38) ALOX15ALOX12HSD17B10ERN1APP
SCHEMBL491265 0.77 HSD17B10 (0.34) ALOX15ALOX12HSD17B10CA2CA4
SCHEMBL16758731 0.77 TDP1 (0.46) ALOX12TDP1ALOX5PTGS2CYP3A4
SCHEMBL19208027 0.76 ACHE (0.39) ALOX15ERN1TDP1CYP3A4MAPT
SCHEMBL1636132 0.76 HSD17B10 (0.33) ALOX15ALOX12HSD17B10MAPTCA2
SCHEMBL3932720 0.76 ALDH1A1 (0.43) ERN1TDP1ALOX5PTGS2CYP3A4
SCHEMBL15353271 0.74 HSD17B10 (0.32) ALOX15ALOX12HSD17B10APPCA2
SCHEMBL29015550 0.74 POLB (0.34) ALOX15ALOX12HSD17B10TDP1APP
SCHEMBL19208031 0.74 TDP1 (0.33) TDP1CYP3A4MAPT
SCHEMBL19208034 0.74 ERN1 (0.35) HSD17B10ERN1TDP1CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113264945-B Spiro derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2022-11-22 CN disclosed
CN-113264945-A Spiro derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2021-08-17 CN disclosed
CN-108601781-B As the 3,5- disubstituted pyrazole of test point kinases 1 (CHK1) inhibitor and its preparation and application 广州必贝特医药技术有限公司 2019-11-22 CN disclosed
EP-3411036-A1 3,5-DISUBSTITUTED PYRAZOLES USEFUL AS CHECKPOINT KINASE 1 (CHK1) INHIBITORS, AND THEIR PREPARATIONS AND APPLICATIONS Pharmaengine, Inc. (TW) 2018-12-12 EP disclosed
WO-2017132928-A1 3,5-DISUBSTITUTED PYRAZOLES USEFUL AS CHECKPOINT KINASE 1 (CHK1) INHIBITORS, AND THEIR PREPARATIONS AND APPLICATIONS PHARMAENGINE, INC. (CN) 2017-08-10 WO disclosed